Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.60 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15488393 | 0.98 | ALDH1A1 (0.58) | ALDH1A1TDP1ADRA2BPTGS1KDM4E | |
| SCHEMBL630768 | 0.83 | CA1 (0.58) | ALDH1A1TDP1ADRA2BPTGS1KDM4E | |
| SCHEMBL396830 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TDP1ADRA2BPTGS1KDM4E | |
| SCHEMBL19712987 | 0.79 | ALDH1A1 (0.47) | ALDH1A1TDP1ADRA2BPTGS1KDM4E | |
| SCHEMBL1429875 | 0.79 | IDO1 (0.48) | ALDH1A1TDP1ADRA2BPTGS1KDM4E | |
| SCHEMBL6828480 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TDP1ADRA2BPTGS1KDM4E | |
| SCHEMBL20294485 | 0.78 | ALDH1A1 (0.46) | ALDH1A1TDP1ADRA2BPTGS1KDM4E | |
| SCHEMBL5205296 | 0.77 | ALDH1A1 (0.64) | ALDH1A1TDP1ADRA2BPTGS1KDM4E | |
| SCHEMBL19878952 | 0.77 | MCHR1 (0.46) | ALDH1A1TDP1ADRA2BPTGS1KDM4E | |
| SCHEMBL13537676 | 0.77 | CYP1A2 (0.44) | ALDH1A1TDP1ADRA2BPTGS1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087442-A1 | AMINO-IMIDAZOLE ANTIBACTERIAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2026-04-30 | — | — | WO | disclosed |
| US-12485109-B2 | Pyrrolo 12.3-dipyrimidine compounds and analogues thereof | BIOCRYST PHARMACEUTICALS, INC. (US) | 2025-12-02 | — | — | US | disclosed |
| EP-4598933-A1 | PHOSPHORAMIDATE COMPOUNDS AND USES THEREOF | Allorion Therapeutics Inc (US) | 2025-08-13 | — | — | EP | disclosed |
| US-12338230-B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2025-06-24 | — | — | US | disclosed |
| EP-4558511-A2 | GLUCOCORTICOID RECEPTOR AGONISTS AND CONJUGATES THEREOF | Firefly Bio, Inc. (US) | 2025-05-28 | — | — | EP | disclosed |
| CN-119968377-A | Phosphoramidate compounds and uses thereof | 安锐生物医药公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2024238872-A2 | ISOINDOLINONE-GLUTARIMIDE ANTIBODY CONJUGATES, AND USES THEREOF | FIREFLY BIO, INC. (US) | 2024-11-21 | — | — | WO | disclosed |
| US-20240368115-A1 | REGULATOR CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHUJING BIOPHARMA CO., LTD (CN) | 2024-11-07 | — | — | US | disclosed |
| WO-2024220236-A2 | HYDROXYLAMINE-BASED BCR-ABL1 INHIBITORS FOR TREATMENT OF CANCER | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-10-24 | — | — | WO | disclosed |
| CN-114026073-B | Quinazolin-4-one derivatives for the treatment of BRAF related diseases and disorders | ARRAY生物制药公司 | 2024-08-23 | — | — | CN | disclosed |
| WO-2004103996-A1 | HEPATITIS C INHIBITOR COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-12-02 | — | — | WO | disclosed |
| CN-1158238-C | Haloacetophenone derivative and its synthesis process | 大连绿源新化学药业股份有限公司 | 2004-07-21 | — | — | CN | disclosed |
| EP-1242406-B1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2004-03-17 | — | — | EP | disclosed |
| WO-2004011460-A2 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | QLT, INC. (CA) | 2004-02-05 | — | — | WO | disclosed |
| CN-1447797-A | New process for preparing quinolone-carboxylic acid | DALIAN LYNCHEM CO LTD (CN) | 2003-10-08 | — | — | CN | disclosed |
| CN-1434818-A | Novel compounds | ASTRAZENECA AB (SE) | 2003-08-06 | — | — | CN | disclosed |
| US-20030036552-A1 | Novel compounds | ASTRAZENECA AB (SE) | 2003-02-20 | — | — | US | disclosed |
| EP-1242406-A1 | NOVEL COMPOUNDS | AstraZeneca AB (SE) | 2002-09-25 | — | — | EP | disclosed |
| CN-1320591-A | Haloacetophenone derivative and its synthesis process | LUYUAN INDUSTRY CO LTD DALIAN (CN) | 2001-11-07 | — | — | CN | disclosed |
| WO-2001046263-A1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2001-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368115-A1 | REGULATOR CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | TPH1, TPH2, GAP43 | ALDH1A1 2405/4885TDP1 1811/4885ADRA2B 54/4885 |
| US-12485109-B2 | Pyrrolo 12.3-dipyrimidine compounds and analogues thereof | C5, DPYD, C9 | ALDH1A1 1373/4885TDP1 173/4885ADRA2B 4482/4885 |
| US-12338230-B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders | CFD, TFPI, CFH | ALDH1A1 2717/4885TDP1 4053/4885ADRA2B 1916/4885 |
| US-20030036552-A1 | Novel compounds | ARRB1, OPRK1, OPRM1 | ALDH1A1 383/4885TDP1 2487/4885ADRA2B 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.